Abstract
Mesenchymal stem cells (MSCs) have been demonstrated to be efficacious in clinical applications for the amelioration of immune disorders, including graft-versus-host disease (GvHD) and Crohn's disease. The immunosuppressive role of Programmed death-ligand 1 (PD-L1) in MSCs is pivotal, yet the regulatory mechanisms governing its expression remain to be fully elucidated. In this study, we explored the influence of paired-related homeobox (PRRX1), a determinant of multipotency and self-renewal in MSCs, on the expression of various surface antigens, notably PD-L1. Multiple isoforms of PRRX1 were found to augment the mRNA levels of MSC markers, such as CD26 and CD317, with all isoforms elevating PD-L1 expression at both mRNA and protein levels. This study reveals that PRRX1 may act as a potential immunomodulatory factor in MSCs by regulating the PD-L1 pathway.
Original language | English |
---|---|
Article number | 102223 |
Pages (from-to) | 1132-1137 |
Number of pages | 6 |
Journal | In Vitro Cellular and Developmental Biology - Animal |
Volume | 60 |
Issue number | 10 |
DOIs | |
Publication status | Published - Dec 2024 |
Keywords
- Immunomodulation
- Mesenchymal stem cells
- Paired-related homeobox 1
- Programmed death-ligand 1
ASJC Scopus subject areas
- Developmental Biology
- Cell Biology